Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal […]
Read MoreProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system PLX $1.9200 0.0300 % 1.5900 Protalix Biotherapeutics Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 1.59% Wk: […]
Read MoreMorphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. MORF $59.2200 1.6300 % 2.8300 Morphic Holding Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: […]
Read MoreAxsome Therapeutics, Inc. (AXSM) Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Exact Sciences Corporation (EXAS) Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Olema Pharmaceuticals, Inc. (OLMA) Olema Pharmaceuticals, Inc., a […]
Read MorePowell Industries, Inc. (POWL) Powell Industries, Inc., together with its subsidiaries, designs, develops, manufactures, sells, and services custom-engineered equipment and systems for the distribution, control, and monitoring of electrical energy. Wave Life Sciences Ltd. (WVE) Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery […]
Read MoreA clinical-stage company, engages in the development of transformational treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. AKRO $53.7000 -1.5100 % -2.7400 Akero Therapeutics Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: -2.74% Wk: […]
Read More89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. ETNB $20.8600 -0.5300 % -2.4800 89Bio Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: -2.48% Wk: 6.1% Mo: 21.05% Yrly: 579.05% […]
Read More89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. ETNB $18.0700 0.7900 % 4.5700 89Bio Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 4.57% Wk: -0.23% Mo: 3.91% Yrly: 517.14% […]
Read MoreBuy Price: $15.30 or better Sell Price: TradersPro Sell Signal Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. The stocks found in the One Hot Stock category use stocks that are in long term, short term trends and are early in the buy signal […]
Read MoreBuy Price: $60.30 or better Sell Price: TradersPro Sell Signal Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. The stocks found in the One Hot Stock category use stocks that are in long term, short term trends […]
Read MoreOncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. ONCY $1.7400 0.1300 % 8.0700 Oncolytics Biotech Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 8.07% Wk: 7.41% Mo: 48.72% Yrly: 55.36% […]
Read MoreMoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. MLTX $27.6400 0.6800 % 2.5200 Moonlake Immunotherapeutics Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 2.52% Wk: -1.82% Mo: 23.78% […]
Read MoreRoivant Sciences Ltd. focuses on discovery, development, and commercialization of medicines. It develops transformative medicines by building technologies and developing talent in creative ways, leveraging its platform to launch Vants nimble and focuses biopharmaceutical and health technology companies. ROIV $9.2500 -0.1200 % -1.2800 Roivant Sciences Ltd Sector : Medical Industry : Medical – Biomedical Signal […]
Read MoreBuy Price: $13.40 or better Sell Price: TradersPro Sell Signal Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of oncology, non-alcoholic steatohepatitis (NASH), and obesity. The stocks found in the One Hot Stock category use stocks that are in long term, short term trends and are early in […]
Read More89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. ETNB $17.3400 0.6700 % 4.0200 89Bio Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 4.02% Wk: 4.32% Mo: 11.51% Yrly: 634.36% […]
Read More